Second, smokers frequently present with comorbid pulmonary pathologies such as emphysema, chronic obstructive pulmonary disease, inflammation, and fibrosis (42), which can interfere with imaging biomarkers associated with EGFR mutations and further reduce model accuracy. This evidence concerns the gene EGFR and pulmonary emphysema.